ES2071275T3 - Producto oftalmico. - Google Patents

Producto oftalmico.

Info

Publication number
ES2071275T3
ES2071275T3 ES91500033T ES91500033T ES2071275T3 ES 2071275 T3 ES2071275 T3 ES 2071275T3 ES 91500033 T ES91500033 T ES 91500033T ES 91500033 T ES91500033 T ES 91500033T ES 2071275 T3 ES2071275 T3 ES 2071275T3
Authority
ES
Spain
Prior art keywords
nanocapsules
ophthalmic product
ophthalmic
application
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91500033T
Other languages
English (en)
Inventor
Philippe Maincent
Laurent Marchal-Heussler
Daniel Sirdat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Cusi SA
Original Assignee
Laboratorios Cusi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Cusi SA filed Critical Laboratorios Cusi SA
Application granted granted Critical
Publication of ES2071275T3 publication Critical patent/ES2071275T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Electroluminescent Light Sources (AREA)

Abstract

PRODUCTO OFTALMICO COMPRENDIENDO NANOCAPSULAS, PROCESO PARA SU PREPARACION Y APLICACION DE LAS NANOCAPSULAS. ESTA INVENCION SE REFIERE A UN PRODUCTO OFTALMICO COMPRENDIENDO NANOCAPSULAS, CARACTERIZADAS POR UN NUCLEO CENTRAL DE NATURALEZA LIPIDA RODEADO POR UNA MEMBRANA POLIMERICA CAPAZ DE ADHERIRSE A TEJIDOS BIOLOGICOS. ESTA INVENCION TAMBIEN SE REFIERE A SU PREPARACION Y A LA APLICACION DE LAS NANOCAPSULAS PARA USO OFTALMICO.-
ES91500033T 1990-04-03 1991-04-02 Producto oftalmico. Expired - Lifetime ES2071275T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9004491A FR2660193B1 (fr) 1990-04-03 1990-04-03 Produit opthalmique comportant des nanocapsules, son procede de preparation et utilisation des nanocapsules.

Publications (1)

Publication Number Publication Date
ES2071275T3 true ES2071275T3 (es) 1995-06-16

Family

ID=9395546

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91500033T Expired - Lifetime ES2071275T3 (es) 1990-04-03 1991-04-02 Producto oftalmico.

Country Status (9)

Country Link
US (1) US5308624A (es)
EP (1) EP0451082B1 (es)
JP (1) JPH0723325B2 (es)
AT (1) ATE116846T1 (es)
DE (1) DE69106560T2 (es)
DK (1) DK0451082T3 (es)
ES (1) ES2071275T3 (es)
FR (1) FR2660193B1 (es)
GR (1) GR3015693T3 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2034891B1 (es) * 1991-08-08 1993-12-16 Cusi Lab Procedimiento de elaboracion en continuo de sistemas coloidales dispersos, en forma de nanocapsulas o nanoparticulas.
FR2692167B1 (fr) * 1992-06-16 1994-09-16 Centre Nat Rech Scient Préparation et application de nouveaux systèmes colloïdaux nanovésiculaires dispersibles à base de cyclodextrine, sous forme de nanocapsules.
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
US5961970A (en) * 1993-10-29 1999-10-05 Pharmos Corporation Submicron emulsions as vaccine adjuvants
US5877224A (en) 1995-07-28 1999-03-02 Rutgers, The State University Of New Jersey Polymeric drug formulations
FR2766368B1 (fr) * 1997-07-24 2000-03-31 Univ Claude Bernard Lyon Procede de preparation de nanocapsules de type vesiculaire, utilisables notamment comme vecteurs colloidaux de principes actifs pharmaceutiques ou autres
DE19756314C2 (de) * 1997-12-12 2000-06-29 Roland Bodmeier Zubereitung mit verlängerter Verweildauer am Applikationsort
JP2001527040A (ja) * 1997-12-30 2001-12-25 バイオアブソーバブル コンセプツ，インコーポレイティド 神経系の脳血管性疾患を治療、抑制及び防止するためのテトラサイクリン及び／又はテトラサイクリン誘導体
DK1075265T3 (da) * 1998-05-08 2006-06-26 Univ Miami Anvendelse af tetracycliner til behandling af sygdom i de Meibomske kirtler
US6432934B1 (en) * 1998-08-06 2002-08-13 Advanced Vision Research Methods and compositions for topical treatment of eye surface inflammation and related dry eye disease
CA2404737C (en) * 2000-04-03 2010-06-29 Santen Pharmaceutical Co., Ltd. Drug delivering substance containing polyalkylene glycol and phospholipid covalently bonded to drug
AU2001280165A1 (en) * 2000-08-24 2002-03-04 Santen Pharmaceutical Co. Ltd. Drug-release controlling system
US20060194773A1 (en) * 2001-07-13 2006-08-31 Paratek Pharmaceuticals, Inc. Tetracyline compounds having target therapeutic activities
EP2329826A1 (en) 2001-07-13 2011-06-08 Paratek Pharmaceuticals, Inc. Tetracyclines for the treatment of multiple sclerosis
WO2003028765A1 (fr) * 2001-09-28 2003-04-10 Santen Pharmaceutical Co., Ltd. Injections pour tissu oculaire contenant un medicament lie a du polyethylene glycol
US20060057216A1 (en) * 2004-09-15 2006-03-16 Salamone Joseph C Low-obscuration image transmitting particulate ocular therapeutic formulations
JP2006257080A (ja) * 2005-02-18 2006-09-28 Santen Pharmaceut Co Ltd ステロイド化合物の副作用軽減または回避方法
CN109646422A (zh) * 2019-01-18 2019-04-19 广东药科大学 一种聚丙烯酸树脂包裹载药蒙脱石的眼部给药系统的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795436A (en) * 1983-11-14 1989-01-03 Bio-Mimetics, Inc. Bioadhesive composition and method of treatment therewith
FR2608942B1 (fr) * 1986-12-31 1991-01-11 Centre Nat Rech Scient Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanocapsules
DE3722837A1 (de) * 1987-07-10 1989-01-19 Ruetgerswerke Ag Ophthalmisches depotpraeparat
US4997652A (en) * 1987-12-22 1991-03-05 Visionex Biodegradable ocular implants
US4853224A (en) * 1987-12-22 1989-08-01 Visionex Biodegradable ocular implants

Also Published As

Publication number Publication date
JPH04221322A (ja) 1992-08-11
FR2660193A1 (fr) 1991-10-04
DE69106560D1 (de) 1995-02-23
US5308624A (en) 1994-05-03
ATE116846T1 (de) 1995-01-15
EP0451082A1 (en) 1991-10-09
FR2660193B1 (fr) 1994-11-04
JPH0723325B2 (ja) 1995-03-15
EP0451082B1 (en) 1995-01-11
GR3015693T3 (en) 1995-07-31
DE69106560T2 (de) 1995-05-11
DK0451082T3 (da) 1995-06-19

Similar Documents

Publication Publication Date Title
ES2071275T3 (es) Producto oftalmico.
DE59100830D1 (de) Verfahren zur Herstellung von 3-Aminomethyl-3,5,5,-trimethyl-cyclohexylamin.
MA22481A1 (fr) Procede de preparation d'acides imidazolyl - alcenoiques .
DE59003791D1 (de) Verfahren zur Herstellung von 1,3,3-Trimethyl-5-oxo-cyclohexan-carbonitril.
DE69009614D1 (de) Verfahren zur Herstellung von (S)-gamma-Hydroxymethyl-alpha,beta-Butenolid.
DE69006911D1 (de) Verfahren zur Herstellung von 3,4-Dichloranilin.
DE59105348D1 (de) Verfahren zur Herstellung von 1,4-Alkylendiaminen.
DE69008617D1 (de) Verfahren zur Herstellung von hydrophobem Material.
DE69009682D1 (de) Verfahren zur Herstellung von Cyclohexanolderivaten.
PT90311A (pt) Processo para a obtencao de proteinas antigenicas imunoprotectoras contra bacterias patogenicas
DE69007965D1 (de) Apparatur zur herstellung von alpha-beta-ungesättigten nitrilen.
DE69013132D1 (de) Verfahren zur Herstellung von Octa-2,7-dien-1-ol.
DE58901037D1 (de) Vorrichtung zur herstellung von klareisstuecken.
DE3851306D1 (de) Verfahren zur Herstellung von optisch-aktiven 1,2-Diolen.
DE68905657D1 (de) Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen.
DE69009394D1 (de) Verfahren zur Herstellung von 3-Cyano-3,5,5-trimethyl-1-cyclohexanon.
DE59003230D1 (de) Verfahren zur Herstellung von 2,4- bzw. 2,6-Dihalogen-anilin.
DE69007895D1 (de) Verfahren zur Herstellung von N-alkylsubstituierten Aminophenolen.
DE59103040D1 (de) Verfahren zur Herstellung von symmetrischen 2,2'-Methylen-bis-benztriazolylphenolen.
DE69010608D1 (de) Verfahren zur Herstellung von 1,1-Diarylethanen.
DE69018028D1 (de) Verfahren zur Herstellung von 2-substituierten-1,4-Naphtochinonen.
DE69019910D1 (de) Verfahren zur Herstellung von 1-Indanonderivaten.
DE59006265D1 (de) Verfahren zur Herstellung von 2-Amino-4-fluorpyrimidinderivaten.
DE69625562D1 (de) Verfahren zur Herstellung von optisch aktiven Cyclohexanolderivaten
DE59106016D1 (de) Verfahren zur Herstellung von 2,3-Dihydrobenzofuranen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 451082

Country of ref document: ES